Granite Investment Partners’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-60,473
Closed -$3.79M 282
2026
Q1
$3.79M Buy
60,473
+1,003
+2% +$80.2K 0.23% 129
2025
Q4
$5.67M Buy
59,470
+26,995
+83% +$2.65M 0.34% 100
2025
Q3
$3.17M Sell
32,475
-1,765
-5% -$183K 0.18% 132
2025
Q2
$3.68M Buy
+34,240
New +$3.46M 0.18% 141

Other funds holding BSX

Granite Investment Partners's BSX Position: Q2 2026 in Review

Granite Investment Partners sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 60,473 shares — an estimated $3.79M sold.

Granite Investment Partners first reported a position in BSX in Q2 2025 and held it in 4 quarters. The position peaked at $5.67M in Q4 2025. 770 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Granite Investment Partners reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Granite Investment Partners sold 60,473 Boston Scientific shares in Q2 2026, an estimated $3.79M.
  • Granite Investment Partners first reported a position in Boston Scientific in Q2 2025 and held it in 4 quarters.
  • Granite Investment Partners's Boston Scientific position peaked at $5.67M in Q4 2025.
  • 770 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Granite Investment Partners's 13F filing for Q2 2026, filed 7 Aug 2026.